Published in Atherosclerosis on December 20, 1996
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med (2011) 13.55
High-density lipoprotein cholesterol efflux, nitration of apolipoprotein A-I, and endothelial function in obese women. Am J Cardiol (2011) 0.82
High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity. Prog Cardiovasc Dis (2015) 0.80
Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study. Sci Rep (2016) 0.80
Impaired Cholesterol Efflux Capacity of High-Density Lipoprotein Isolated From Interstitial Fluid in Type 2 Diabetes Mellitus-Brief Report. Arterioscler Thromb Vasc Biol (2016) 0.79
Triacylglycerol-rich lipoproteins alter the secretion, and the cholesterol-effluxing function, of apolipoprotein E-containing lipoprotein particles from human (THP-1) macrophages. Biochem J (2001) 0.79
Endothelial lipase and reverse cholesterol transport in type 2 diabetes mellitus. J Diabetes Investig (2010) 0.78
Atherogenic dyslipidemia and combination pharmacotherapy in diabetes: recent clinical trials. Rev Diabet Stud (2013) 0.77
Association of Cholesterol Efflux Capacity With Clinical Features of Metabolic Syndrome: Relevance to Atherosclerosis. J Am Heart Assoc (2016) 0.75
Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care (2001) 14.03
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet (2005) 13.18
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83
Blood group M specific haemagglutinin in pyelonephritogenic Escherichia coli. Lancet (1982) 2.56
Association of apolipoprotein E E4 with vascular dementia. JAMA (1994) 2.48
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes (1999) 2.36
Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes (1996) 2.33
Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity. Nat Med (2005) 2.28
A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest (1980) 2.27
Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91
Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes (2000) 1.90
Somatic gene transfer of human ApoA-I inhibits atherosclerosis progression in mouse models. Circulation (1999) 1.88
Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care (2000) 1.76
Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered (1999) 1.76
Dissecting the role of the golgi complex and lipid rafts in biosynthetic transport of cholesterol to the cell surface. Proc Natl Acad Sci U S A (2000) 1.67
Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis (1991) 1.66
Serum complement and familial combined hyperlipidemia. Atherosclerosis (1997) 1.64
Elevated fasting plasma insulin in a general aged population: an innocent companion of cardiovascular diseases. J Am Geriatr Soc (1997) 1.59
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia (2010) 1.53
Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat Genet (1998) 1.52
The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia (2001) 1.51
Disposition of metformin (N,N-dimethylbiguanide) in man. Clin Pharmacol Ther (1978) 1.50
Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res (1986) 1.50
Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia (1997) 1.49
Lipid intolerance in smokers. J Intern Med (1995) 1.48
Effect of muscular exercise on insulin secretion. Diabetes (1968) 1.48
Effect of diet on serum lipoproteins in a population with a high risk of coronary heart disease. N Engl J Med (1982) 1.45
Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes (2002) 1.43
Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem (1993) 1.43
Potential gene therapy for lecithin-cholesterol acyltransferase (LCAT)-deficient and hypoalphalipoproteinemic patients with adenovirus-mediated transfer of human LCAT gene. Circulation (1996) 1.43
An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta (1975) 1.43
The OSBP-related protein family in humans. J Lipid Res (2001) 1.40
Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science (1996) 1.39
Purification and characterization of lipoprotein lipase from pig adipose tissue. J Biol Chem (1974) 1.39
Multidisciplinary biopsychosocial rehabilitation for subacute low back pain in working-age adults: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine (Phila Pa 1976) (2001) 1.37
Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation (1995) 1.35
Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia (2007) 1.34
Multidisciplinary biopsychosocial rehabilitation for subacute low back pain among working age adults. Cochrane Database Syst Rev (2003) 1.34
Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet (1993) 1.34
Multidisciplinary biopsychosocial rehabilitation for neck and shoulder pain among working age adults. Cochrane Database Syst Rev (2003) 1.33
Changes in serum lipoprotein pattern induced by acute infections. Metabolism (1988) 1.32
Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis (1994) 1.32
Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study. Diabetologia (2011) 1.32
Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima. J Lipid Res (1988) 1.31
Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study. Circulation (2001) 1.31
Cloning and expression of human apolipoprotein D cDNA. J Biol Chem (1986) 1.30
Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. J Clin Invest (1997) 1.30
The mechanism of the remodeling of high density lipoproteins by phospholipid transfer protein. J Biol Chem (2001) 1.30
The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis (2001) 1.29
Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol (1995) 1.29
Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest (1997) 1.27
Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem J (1997) 1.27
Apolipoprotein E and B polymorphisms--longevity factors assessed in nonagenarians. Atherosclerosis (1994) 1.25
Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest (1987) 1.25
Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism. Diabetes (1977) 1.23
Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. J Biol Chem (1983) 1.23
Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working age adults. Cochrane Database Syst Rev (2000) 1.23
Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am J Hum Genet (1999) 1.21
Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources. Am J Physiol (1991) 1.20
Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol (2000) 1.20
Lipoprotein lipase in diabetes. Diabetes Metab Rev (1987) 1.19
Oncoplastic techniques in the conservative surgical treatment of breast cancer. Breast Cancer (2000) 1.19
The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. Biochem J (1996) 1.19
Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: relation to serum lipoproteins. Metabolism (1978) 1.18
Serum cholesterol concentration and mortality from accidents, suicide, and other violent causes. BMJ (1994) 1.18
Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol (1997) 1.17
Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation (1996) 1.17
Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits. Circulation (1996) 1.17
The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences. Diabetes (2001) 1.17
Cholesterol efflux capacity in vitro predicts the severity and extent of coronary artery disease in patients with and without type 2 diabetes. Scand Cardiovasc J (2001) 1.16
Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia (1996) 1.16
Intense physical training decreases circulating antioxidants and endothelium-dependent vasodilatation in vivo. Atherosclerosis (1999) 1.16
Interaction of Munc-18-2 with syntaxin 3 controls the association of apical SNAREs in epithelial cells. J Cell Sci (1998) 1.16
Human plasma lecithin-cholesterol acyltransferase. An elucidation of the catalytic mechanism. J Biol Chem (1986) 1.15
Metabolic effects of metformin in patients with impaired glucose tolerance. Diabet Med (2001) 1.15
Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med (1994) 1.15
Purification and quantitation of the human plasma lipoprotein carrying the Lp(a) antigen. Biochim Biophys Acta (1971) 1.14
PCR amplification of alleles at the DIS80 locus: comparison of a Finnish and a North American Caucasian population sample, and forensic casework evaluation. Am J Hum Genet (1992) 1.13
Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res (1989) 1.13
Hepatic lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice. J Biol Chem (1997) 1.12
Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes (1998) 1.11
ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J Lipid Res (2001) 1.11
Effect of moderate physical exercise on serum lipoproteins. A controlled clinical trial with special reference to serum high-density lipoproteins. Circulation (1979) 1.10
Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol (1995) 1.10
Membrane insertion and intracellular transport of yeast syntaxin Sso2p in mammalian cells. J Cell Sci (1994) 1.10